Follow-Up Frequency for Patients with Hyperlipidemia and Hypothyroidism

Monitoring Schedule for Hyperlipidemia

The American Diabetes Association recommends obtaining a baseline lipid profile before initiating statin therapy to establish a reference point 4, 5
The American College of Cardiology recommends checking LDL cholesterol 4-12 weeks after starting statin therapy or after any dose change to assess initial response 1, 4
For patients on stable statin therapy with good response, the American Heart Association recommends obtaining lipid profiles annually 1, 3
More frequent monitoring (every 3-6 months) may be necessary for patients with suboptimal LDL response, medication adherence concerns, or very high cardiovascular risk 5
For elderly patients (>75 years) with stable LDL levels at goal, monitoring can be less frequent than annual 6

The American College of Physicians recommends that patients with stable, well-controlled hypothyroidism have thyroid function tests performed annually 2

The American College of Physicians recommends seeing patients with well-controlled hyperlipidemia and hypothyroidism every 6-12 months 2, 3
At each visit, the American Heart Association recommends reviewing medication adherence and side effects, assessing for symptoms of under or over-treatment, performing targeted physical examination, and ordering appropriate laboratory tests based on monitoring schedule 1, 2

Failing to obtain baseline laboratory values before starting therapy can be avoided by following guidelines from the American College of Cardiology 4, 5
Waiting too long to assess initial response to medication changes can be avoided by following guidelines from the American Heart Association 4
Not reassessing annually can miss changes in adherence patterns or developing resistance, according to the American Diabetes Association 1, 3
Unnecessarily frequent testing in stable elderly patients can lead to overutilization of healthcare resources, as noted by the American Geriatrics Society 6